TFEB/LAMP2 contributes to PM-induced autophagy-lysosome dysfunction and alpha-synuclein dysregulation in astrocytes.

Journal: Journal of environmental sciences (China)
PMID:

Abstract

Atmospheric particulate matter (PM) exacerbates the risk factor for Alzheimer's and Parkinson's diseases (PD) by promoting the alpha-synuclein (α-syn) pathology in the brain. However, the molecular mechanisms of astrocytes involvement in α-syn pathology underlying the process remain unclear. This study investigated PM with particle size <200 nm (PM) exposure-induced α-syn pathology in ICR mice and primary astrocytes, then assessed the effects of mammalian target of rapamycin inhibitor (PP242) in vitro studies. We observed the α-syn pathology in the brains of exposed mice. Meanwhile, PM-exposed mice also exhibited the activation of glial cell and the inhibition of autophagy. In vitro study, PM (3, 10 and 30 µg/mL) induced inflammatory response and the disorders of α-syn degradation in primary astrocytes, and lysosomal-associated membrane protein 2 (LAMP2)-mediated autophagy underlies α-syn pathology. The abnormal function of autophagy-lysosome was specifically manifested as the expression of microtubule-associated protein light chain 3 (LC3II), cathepsin B (CTSB) and lysosomal abundance increased first and then decreased, which might both be a compensatory mechanism to toxic α-syn accumulation induced by PM. Moreover, with the transcription factor EB (TFEB) subcellular localization and the increase in LC3II, LAMP2, CTSB, and cathepsin D proteins were identified, leading to the restoration of the degradation of α-syn after the intervention of PP242. Our results identified that PM exposure could promote the α-syn pathological dysregulation in astrocytes, providing mechanistic insights into how PM increases the risk of developing PD and highlighting TFEB/LAMP2 as a promising therapeutic target for antagonizing PM toxicity.

Authors

  • Ben Li
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China. Electronic address: LBen@sxmu.edu.cn.
  • Ting Liu
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Yongmei Shen
    Hainan Provincial Center for Disease Control and Prevention, Haikou 570100, China.
  • Jiangnan Qin
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Xiaohan Chang
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Meiqiong Wu
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Jianquan Guo
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Liangpo Liu
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Cailing Wei
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Yi Lyu
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Fengjie Tian
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Jinzhu Yin
    Department of Neurosurgery, Sinopharm Tongmei General Hospital, Datong 037003, China.
  • Tong Wang
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China; Key Laboratory of Coal Environmental Pathogenicity and Prevention (Shanxi Medical University), Ministry of Education, Taiyuan 030000, China.
  • Wenping Zhang
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China.
  • Yulan Qiu
    School of Public Health, Shanxi Medical University, Taiyuan 030000, China. Electronic address: ylqiu@sxmu.edu.cn.